Budget expectations from Vikram Vuppala Founder and CEO, NephroPlus

▴ Vikram Vuppala Founder and CEO, NephroPlus
Additionally, to position India as a global leader in healthcare in line with Vishwaguru philosophy, we urge the government to introduce tax incentives for healthcare services exports and provide robust support for R&D in innovative healthcare services. This will not only benefit millions of patients but also boost India’s stature in the global healthcare ecosystem

"As the government prepares for the 2025 Budget, we hope for a significant increase in funding to expand dialysis services under the PMNDP, addressing the urgent need for dialysis care across the country. Only 15% of patients who require dialysis get access currently. With Lakhs of new patients requiring regular dialysis, increasing dialysis care outlay and thereby increasing access to life sustaining care is crucial.  

Additionally, to position India as a global leader in healthcare in line with Vishwaguru philosophy, we urge the government to introduce tax incentives for healthcare services exports and provide robust support for R&D in innovative healthcare services. This will not only benefit millions of patients but also boost India’s stature in the global healthcare ecosystem" - Vikram Vuppala Founder and CEO, NephroPlus

 

About Vikram Vuppala Founder and CEO, NephroPlus (https://nephroplus.com/)

 

Vikram Vuppala is the Founder & CEO of India’s largest dialysis network - NephroPlus. After spending 10 years in the US healthcare industry, his passion for redefining healthcare delivery in India prompted him to launch NephroPlus in 2010. Today, NephroPlus has expanded to 400+ dialysis clinics in more than 230+ cities across 4 countries. It has rapidly grown under Vikram’s leadership to become the Asia's leading dialysis network.

 

He had raised a Series A Private equity investment of $4.3 MM from Bessemer Venture Partners (BVP) in Nov 2011, a Series B investment of $10 MM in May 2014 from IFC (World Bank arm) and BVP, and a Series C investment of $15 MM in Aug 2016 from IFC and SeaLink Capital. And recently, NephroPlus has secured INR 860 Crores in the Series F round, from Quadria Capital, a Singapore based healthcare-focused private equity firm.

 

Prior to founding NephroPlus, Vikram was a strategy consultant at McKinsey in the US. Vikram with over 18 years of global healthcare experience has helped hospitals, chains of clinics, healthcare distributors, and pharmaceutical clients on various strategic issues such as business development, growth strategy, portfolio rationalisation, and M&A. He has been a speaker at numerous entrepreneurial, healthcare and investment conferences. Vikram did his B. Tech. from IIT-Kharagpur and a full-time MBA from Chicago Booth

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Deworming in Children: A Crucial Step Towards Healthy GrowthFebruary 07, 2025
AI-powered blue-collar hiring platform Vahan.ai secures investment from APAC HR services leader Persol Group amid booming gig economy in India; plans to develop AI recruitment technology to support 8 major Indian languages February 07, 2025
Scars That Never Heal: The Painful Reality of Female Genital MutilationFebruary 06, 2025
Maharashtra’s Healthcare Betrayal: Why Are Crucial Funds Going Unused?February 06, 2025
1vision, 1 mission: Avaada Foundation’s CSR initiatives are powering communities and delivering sustainable progress across 5 key focus areasFebruary 06, 2025
Top 5 Technology Brands that are Transforming the Cancer Care Journeys for Hospitals and PatientsFebruary 06, 2025
Women's Wellness brand NUA Raises Rs 35 Crore in Pre-Series C led by Mirabilis Investment TrustFebruary 06, 2025
8 Effective Ways to Minimize Postpartum ComplicationsFebruary 06, 2025
Does Where You Live Decide Your Fate? The Urban-Rural Breast Cancer Divide in IndiaFebruary 06, 2025
Nepal leads the world with largest pictorial health warnings on all tobacco productsFebruary 05, 2025
Fleetguard Filters Private Limited Recognized for Excellence in CSR at Navabharat’s 4th CSR ConclaveFebruary 05, 2025
Six new regions of the Russian Federation are set to connect to Moscow's AI medical services platform, MosMedAIFebruary 04, 2025
Six new regions of the Russian Federation are set to connect to Moscow's AI medical services platform, MosMedAIFebruary 04, 2025
Ashok Leyland Reinforces ESG Commitment, Ranked No. 1 Globally in Sustainalytics’ RatingsFebruary 04, 2025
Calcium Supplements: Do You Really Need Them?February 04, 2025
Digital Diagnostics Doubles Its Foreign Publication Count in 2024February 04, 2025
World Cancer Day quotesFebruary 04, 2025
India can take a big leap in Cancer Care with Improved access to treatment and People-centered Approach: ExpertsFebruary 04, 2025
Lilly India appoints Winselow Tucker as the President and General ManagerFebruary 04, 2025
Driving Excellence in Clinical Research: ISCR's 18th Annual Conference Highlights Innovation, Technology, and Patient-CentricityFebruary 04, 2025